Back to companies
Protagonist Therapeutics, Inc
PTGXUSNASDAQPharmaceuticals & HealthcareProtagonist Therapeutics, Inc
Revenue
$46.0mn
YoY -89.4%
Operating income
-$158.1mn
FY2025
Employees
—
Founded
—
Source: U.S. Securities and Exchange Commission (SEC) EDGAR Company Facts API